BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9739108)

  • 1. Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats.
    Clarkson ED; Zawada WM; Adams FS; Bell KP; Freed CR
    Brain Res; 1998 Sep; 806(1):60-8. PubMed ID: 9739108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
    Yurek DM
    Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
    Espejo M; Cutillas B; Arenas TE; Ambrosio S
    Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-grafts of muscle cells and mesencephalic tissue into hemiparkinsonian rats: behavioral and histochemical effects.
    Kaddis FG; Clarkson ED; Bell KP; Choi PK; Freed CR
    Brain Res Bull; 2000 Feb; 51(3):203-11. PubMed ID: 10718512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model.
    Nikkhah G; Bentlage C; Cunningham MG; Björklund A
    J Neurosci; 1994 Jun; 14(6):3449-61. PubMed ID: 7911516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells.
    Agrawal AK; Shukla S; Chaturvedi RK; Seth K; Srivastava N; Ahmad A; Seth PK
    Neurobiol Dis; 2004 Aug; 16(3):516-26. PubMed ID: 15262263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
    Terpstra BT; Collier TJ; Marchionini DM; Levine ND; Paumier KL; Sortwell CE
    J Neurosci Methods; 2007 Oct; 166(1):13-9. PubMed ID: 17706789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat.I. Effects on spontaneous activity of striatal neurons.
    Di Loreto S; Florio T; Capozzo A; Napolitano A; Adorno D; Scarnati E
    Exp Neurol; 1996 Apr; 138(2):318-26. PubMed ID: 8620930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats.
    Zawada WM; Zastrow DJ; Clarkson ED; Adams FS; Bell KP; Freed CR
    Brain Res; 1998 Mar; 786(1-2):96-103. PubMed ID: 9554968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function.
    Frodl EM; Duan WM; Sauer H; Kupsch A; Brundin P
    Brain Res; 1994 Jun; 647(2):286-98. PubMed ID: 7922505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum.
    Granholm AC; Mott JL; Bowenkamp K; Eken S; Henry S; Hoffer BJ; Lapchak PA; Palmer MR; van Horne C; Gerhardt GA
    Exp Brain Res; 1997 Aug; 116(1):29-38. PubMed ID: 9305812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality.
    Sortwell CE; Collier TJ; Camargo MD; Pitzer MR
    Exp Neurol; 2004 May; 187(1):58-64. PubMed ID: 15081588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor.
    Krobert K; Lopez-Colberg I; Cunningham LA
    Exp Neurol; 1997 Jun; 145(2 Pt 1):511-23. PubMed ID: 9217087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells.
    Pitzer MR; Sortwell CE; Daley BF; McGuire SO; Marchionini D; Fleming M; Collier TJ
    Exp Neurol; 2003 Aug; 182(2):435-45. PubMed ID: 12895454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
    Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
    Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model.
    Nikkhah G; Cunningham MG; Jödicke A; Knappe U; Björklund A
    Brain Res; 1994 Jan; 633(1-2):133-43. PubMed ID: 7907929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-I and bFGF improve dopamine neuron survival and behavioral outcome in parkinsonian rats receiving cultured human fetal tissue strands.
    Clarkson ED; Zawada WM; Bell KP; Esplen JE; Choi PK; Heidenreich KA; Freed CR
    Exp Neurol; 2001 Mar; 168(1):183-91. PubMed ID: 11170733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation of young donor age dopaminergic grafts in a GDNF-loaded collagen hydrogel further increases their survival, reinnervation, and functional efficacy after intrastriatal transplantation in hemi-Parkinsonian rats.
    Moriarty N; Cabré S; Alamilla V; Pandit A; Dowd E
    Eur J Neurosci; 2019 Feb; 49(4):487-496. PubMed ID: 30054941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
    Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J
    Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging nigrostriatal pathway with fibroblast growth factor-primed peripheral nerves and fetal ventral mesencephalon transplant recuperates from deficits in parkinsonian rats.
    Chiang YH; Lin SZ; Zhou FC
    Cell Transplant; 2006; 15(6):475-82. PubMed ID: 17121158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.